BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liu H, Li P, Zhai Y, Qu CF, Zhang LJ, Tan YF, Li N, Ding HG. Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma. World J Gastroenterol 2010; 16(35): 4410-4415 [PMID: 20845507 DOI: 10.3748/wjg.v16.i35.4410]
URL: https://www.wjgnet.com/1948-5182/full/v16/i35/4410.htm
Number Citing Articles
1
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_3-1
2
Manuele Gori, Mario Arciello, Clara Balsano. MicroRNAs in Nonalcoholic Fatty Liver Disease: Novel Biomarkers and Prognostic Tools during the Transition from Steatosis to HepatocarcinomaBioMed Research International 2014; 2014: 1 doi: 10.1155/2014/741465
3
Michele Dal Bo, Elena De Mattia, Lorena Baboci, Silvia Mezzalira, Erika Cecchin, Yehuda G. Assaraf, Giuseppe Toffoli. New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinomaDrug Resistance Updates 2020; 51: 100702 doi: 10.1016/j.drup.2020.100702
4
Robert J. Wong, Aijaz Ahmed, Robert G. Gish. Elevated Alpha-FetoproteinClinics in Liver Disease 2015; 19(2): 309 doi: 10.1016/j.cld.2015.01.005
5
Marina Curado Valsechi, Ana Beatriz Bortolozo Oliveira, André Luis Giacometti Conceição, Bruna Stuqui, Natalia Maria Candido, Paola Jocelan Scarin Provazzi, Luiza Ferreira de Araújo, Wilson Araújo Silva, Marilia de Freitas Calmon, Paula Rahal. GPC3 reduces cell proliferation in renal carcinoma cell linesBMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-631
6
Yukihiro Haruyama, Kenji Yorita, Tetsuji Yamaguchi, Sachiko Kitajima, Jun Amano, Toshihiko Ohtomo, Akinobu Ohno, Kazuhiro Kondo, Hiroaki Kataoka. High preoperative levels of serum glypican‐3 containing N‐terminal subunit are associated with poor prognosis in patients with hepatocellular carcinoma after partial hepatectomyInternational Journal of Cancer 2015; 137(7): 1643 doi: 10.1002/ijc.29518
7
Chao-Wei Lee, Hsin-I Tsai, Wei-Chen Lee, Shu-Wei Huang, Cheng-Yu Lin, Yi-Chung Hsieh, Tony Kuo, Chun-Wei Chen, Ming-Chin Yu. Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?Journal of Clinical Medicine 2019; 8(10): 1736 doi: 10.3390/jcm8101736
8
Antonio Junior Lepedda, Gabriele Nieddu, Nikos Karamanos, Marilena Formato. The Extracellular Matrix and the Tumor MicroenvironmentBiology of Extracellular Matrix 2022; 11: 119 doi: 10.1007/978-3-030-99708-3_6
9
Zhao-Shan Niu, Xiao-Jun Niu, Mei Wang. Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survivalWorld Journal of Hepatology 2015; 7(1): 7-27 doi: 10.4254/wjh.v7.i1.7
10
Eric Waidely, Abdul-Rahman Obaid Al-Yuobi, A. S. Bashammakh, Mohammad S. El-Shahawi, Roger M. Leblanc. Serum protein biomarkers relevant to hepatocellular carcinoma and their detectionThe Analyst 2016; 141(1): 36 doi: 10.1039/C5AN01884F
11
Abdelfattah M. Attallah, Mohamed El-Far, Mohamed M. Omran, Mohamed A. Abdelrazek, Ahmed A. Attallah, Aya M. Saeed, Khaled Farid. GPC-HCC model: a combination of glybican-3 with other routine parameters improves the diagnostic efficacy in hepatocellular carcinomaTumor Biology 2016; 37(9): 12571 doi: 10.1007/s13277-016-5127-6
12
Zheng Guo, Jing Wang, Li Li, Rong Liu, Jin Fang, Bin Tie. Value of miR-1271 and glypican-3 in evaluating the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolizationWorld Journal of Clinical Cases 2020; 8(16): 3493-3502 doi: 10.12998/wjcc.v8.i16.3493
13
Chunmei Xie, Christian Tiede, Xuanyi Zhang, Congrong Wang, Zhixiong Li, Xiao Xu, Michael J. McPherson, Darren C. Tomlinson, Weiwen Xu. Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-10083-w
14
Davide Busato, Monica Mossenta, Lorena Baboci, Federica Di Cintio, Giuseppe Toffoli, Michele Dal Bo. Novel immunotherapeutic approaches for hepatocellular carcinoma treatmentExpert Review of Clinical Pharmacology 2019; 12(5): 453 doi: 10.1080/17512433.2019.1598859
15
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 65 doi: 10.1007/978-3-319-26956-6_3
16
Yu‑Xue Gao, Tong‑Wang Yang, Ji‑Ming Yin, Peng‑Xiang Yang, Bu‑Xin Kou, Meng‑Yin Chai, Xiao‑Ni Liu, De‑Xi Chen. Progress and prospects of biomarkers in�primary liver cancer (Review)International Journal of Oncology 2020;  doi: 10.3892/ijo.2020.5035
17
Hui‐Lai Miao, Chang‐Jiang Lei, Zhi‐Dong Qiu, Zhong‐Kao Liu, Ran Li, Shi‐Ting Bao, Ming‐Yi Li. MicroRNA‐520c‐3p inhibits hepatocellular carcinoma cell proliferation and invasion through induction of cell apoptosis by targeting glypican‐3Hepatology Research 2014; 44(3): 338 doi: 10.1111/hepr.12121
18
Yanyan Xia, Yuanying Zhang, Mengjiao Shen, Hongpan Xu, Zhiyang Li, Nongyue He. Golgi protein 73 and its diagnostic value in liver diseasesCell Proliferation 2019; 52(2) doi: 10.1111/cpr.12538
19
Stevan A. Gonzalez, Emmet B. Keeffe. Diagnosis of Hepatocellular Carcinoma: Role of Tumor Markers and Liver BiopsyClinics in Liver Disease 2011; 15(2): 297 doi: 10.1016/j.cld.2011.03.012
20
Taofic Mounajjed, Lizhi Zhang, Tsung-Teh Wu. Glypican-3 expression in gastrointestinal and pancreatic epithelial neoplasmsHuman Pathology 2013; 44(4): 542 doi: 10.1016/j.humpath.2012.06.016
21
Yukihiro Haruyama, Hiroaki Kataoka. Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinomaWorld Journal of Gastroenterology 2016; 22(1): 275-283 doi: 10.3748/wjg.v22.i1.275
22
Ovidiu Preda, Francisco F. Nogales. Pathology and Biology of Human Germ Cell Tumors2017; : 131 doi: 10.1007/978-3-662-53775-6_4
23
Anusha H. Tennakoon, Takeshi Izawa, Kavindra K. Wijesundera, Chisa Katou-Ichikawa, Miyuu Tanaka, Hossain M. Golbar, Mitsuru Kuwamura, Jyoji Yamate. Analysis of glial fibrillary acidic protein (GFAP)-expressing ductular cells in a rat liver cirrhosis model induced by repeated injections of thioacetamide (TAA)Experimental and Molecular Pathology 2015; 98(3): 476 doi: 10.1016/j.yexmp.2015.03.010
24
Katharina Wiedemeyer, Martin Köbel, Holly Koelkebeck, Zhan Xiao, Kapil Vashisht. High glypican-3 expression characterizes a distinct subset of ovarian clear cell carcinomas in Canadian patients: an opportunity for targeted therapyHuman Pathology 2020; 98: 56 doi: 10.1016/j.humpath.2020.01.002
25
Francisco F Nogales, Ovidiu Preda, Alina Nicolae. Yolk sac tumours revisited. A review of their many faces and namesHistopathology 2012; 60(7): 1023 doi: 10.1111/j.1365-2559.2011.03889.x
26
ZHIJIAN PAN, CHUNZHOU CHEN, HAOCHENG LONG, CHANGJIANG LEI, GANG TANG, LEI LI, JIARUI FENG, FEIXIANG CHEN. Overexpression of GPC3 inhibits hepatocellular carcinoma cell proliferation and invasion through induction of apoptosisMolecular Medicine Reports 2013; 7(3): 969 doi: 10.3892/mmr.2013.1279
27
Xiao-Fei Liu, Zhi-De Hu, Xiao-Cui Liu, Yuan Cao, Chun-Mei Ding, Cheng-Jin Hu. Diagnostic accuracy of serum glypican-3 for hepatocellular carcinoma: A systematic review and meta-analysisClinical Biochemistry 2014; 47(3): 196 doi: 10.1016/j.clinbiochem.2013.12.007
28
JuanPing Yu, Qiang Ma, Bin Zhang, RuiJuan Ma, XiGuang Xu, MingSong Li, WeiWen Xu, Ming Li. Clinical application of specific antibody against glypican-3 for hepatocellular carcinoma diagnosisScience China Life Sciences 2013; 56(3): 234 doi: 10.1007/s11427-013-4451-y
29
Jian Li, Sun Qiyu, Tiezheng Wang, Boxun Jin, Ning Li. Improving the Detection of Hepatocellular Carcinoma using serum AFP expression in combination with GPC3 and micro-RNA miR-122 expressionOpen Life Sciences 2019; 14(1): 53 doi: 10.1515/biol-2019-0007
30
Mahmoud Khattab, Magdy Fouad, Elham Ahmed. Role of biomarkers in the prediction and diagnosis of hepatocellular carcinomaWorld Journal of Hepatology 2015; 7(23): 2474-2481 doi: 10.4254/wjh.v7.i23.2474
31
Xu Yi, Li Long, Chunzhang Yang, Yingying Lu, Mingliang Cheng, Diego Calvisi. Maotai Ameliorates Diethylnitrosamine-Initiated Hepatocellular Carcinoma Formation in MicePLoS ONE 2014; 9(4): e93599 doi: 10.1371/journal.pone.0093599
32
Monica Mossenta, Davide Busato, Michele Dal Bo, Paolo Macor, Giuseppe Toffoli. Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative TherapiesInternational Journal of Molecular Sciences 2022; 23(17): 10038 doi: 10.3390/ijms231710038
33
Sheng-Li Yang, Xiefan Fang, Zao-Zao Huang, Xiang-Jie Liu, Zhi-Fan Xiong, Ping Liu, Hong-Yi Yao, Chang-Hai Li. Can Serum Glypican-3 Be a Biomarker for Effective Diagnosis of Hepatocellular Carcinoma? A Meta-Analysis of the LiteratureDisease Markers 2014; 2014: 1 doi: 10.1155/2014/127831
34
YONGLE WU, HUI LIU, HONGLEI WENG, XIN ZHANG, PENG LI, CHUN-LEI FAN, BING LI, PEI-LING DONG, LEI LI, STEVEN DOOLEY, HUI-GUO DING. Glypican-3 promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathwayInternational Journal of Oncology 2015; 46(3): 1275 doi: 10.3892/ijo.2015.2827
35
Tarek D. Hussein. Serological tumor markers of hepatocellular carcinoma: a meta-analysisThe International Journal of Biological Markers 2015; 30(1): 32 doi: 10.5301/jbm.5000119
36
Wenqing Cao, Meenal Sharma, Rami Imam, Jiangzhou Yu. Study on Diagnostic Values of Astrocyte Elevated Gene 1 (AEG-1) and Glypican 3 (GPC-3) in Hepatocellular CarcinomaAmerican Journal of Clinical Pathology 2019; 152(5): 647 doi: 10.1093/ajcp/aqz086
37
Yao Wang, Jiaxin Yang, Mei Yu, Dongyan Cao, Ying Zhang, Xuan Zong, Keng Shen. Ovarian yolk sac tumor in postmenopausal femalesMedicine 2018; 97(33): e11838 doi: 10.1097/MD.0000000000011838
38
Gabriela Perdomo CORAL, Fernanda BRANCO, Rosalva MEURER, Patrícia dos Santos MARCON, Paulo Roberto Ott FONTES, Angelo Alves de MATTOS. RESULTS OF IMMUNOHISTOCHEMISTRY IN THE DIFFERENTIAL DIAGNOSIS OF EARLY HEPATOCELLULAR CARCINOMA AND NODULES WITH HIGH-GRADE DYSPLASIA IN PATIENTS WITH CIRRHOSISArquivos de Gastroenterologia 2021; 58(1): 82 doi: 10.1590/s0004-2803.202100000-14
39
Cheng Xu, Zhehui Yan, Liang Zhou, Yuming Wang. A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysisJournal of Cancer Research and Clinical Oncology 2013; 139(8): 1417 doi: 10.1007/s00432-013-1458-5
40
Li Gong, Long-Xiao Wei, Pin Ren, Wen-Dong Zhang, Xiao-Yan Liu, Xiu-Juan Han, Li Yao, Shao-Jun Zhu, Miao Lan, Yan-Hong Li, Wei Zhang, Ferruccio Bonino. Dysplastic Nodules with Glypican-3 Positive Immunostaining: A Risk for Early Hepatocellular CarcinomaPLoS ONE 2014; 9(1): e87120 doi: 10.1371/journal.pone.0087120
41
Iman A. Abd El Gawad, Ghada I. Mossallam, Noha H. Radwan, Heba M. Elzawahry, Niveen M. Elhifnawy. Comparing Prothrombin induced by vitamin K absence-II (PIVKA-II) with the oncofetal proteins Glypican-3, Alpha feto protein and Carcinoembryonic antigen in diagnosing hepatocellular carcinoma among Egyptian patientsJournal of the Egyptian National Cancer Institute 2014; 26(2): 79 doi: 10.1016/j.jnci.2014.01.001
42
Woo-Ri Shin, Dae-Young Park, Ji Hun Kim, Jin-Pyo Lee, Nguyen Quang Thai, In-Hwan Oh, Simranjeet Singh Sekhon, Wooil Choi, Sung Yeon Kim, Byung-Kwan Cho, Sun Chang Kim, Jiho Min, Ji-Young Ahn, Yang-Hoon Kim. Structure based innovative approach to analyze aptaprobe–GPC3 complexes in hepatocellular carcinomaJournal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01391-z
43
Xiaobo Jia, Jiao Liu, Yingtang Gao, Yong Huang, Zhi Du. Diagnosis Accuracy of Serum Glypican-3 in Patients with Hepatocellular Carcinoma: A Systematic Review with Meta-analysisArchives of Medical Research 2014; 45(7): 580 doi: 10.1016/j.arcmed.2014.11.002
44
Li-Li Han, Yi Lv, Hui Guo, Zhi-Ping Ruan, Ke-Jun Nan. Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapyWorld Journal of Gastroenterology 2014; 20(30): 10249-10261 doi: 10.3748/wjg.v20.i30.10249
45
Ruben D. Houvast, Mireille Vankemmelbeke, Lindy G. Durrant, Manfred Wuhrer, Victor M. Baart, Peter J. K. Kuppen, Lioe-Fee de Geus-Oei, Alexander L. Vahrmeijer, Cornelis F. M. Sier. Targeting Glycans and Heavily Glycosylated Proteins for Tumor ImagingCancers 2020; 12(12): 3870 doi: 10.3390/cancers12123870
46
Xiaoting Luo, Xin He, Xingmei Zhang, Xiaohui Zhao, Yuzhe Zhang, Yusheng Shi, Shengni Hua. Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapyMedComm 2024; 5(2) doi: 10.1002/mco2.474
47
Shujian Ge, Yali Xu, Hongliang Wang, Yaxin Sun, Xiangguo Tian, Zhixin Cao, Xiaoyan Lin, Jiawen Xu, Qiangxiu Wang. Downregulation of esophageal cancer-related gene 4 promotes proliferation and migration of hepatocellular carcinomaOncology Letters 2017; 14(3): 3689 doi: 10.3892/ol.2017.6616
48
Nannan Zhang, Zhenni Hu, Yong Qiang, Xiaochao Zhu. Circulating miR‐130b‐ and miR‐21‐based diagnostic markers and therapeutic targets for hepatocellular carcinomaMolecular Genetics & Genomic Medicine 2019; 7(12) doi: 10.1002/mgg3.1012
49
Xiaobo Jia, Yingtang Gao, Daokuan Zhai, Jiao Liu, Junjun Cai, Yajie Wang, Li Jing, Zhi Du. Assessment of the Clinical Utility of Glypican 3 as a Serum Marker for the Diagnosis of Hepatocellular CarcinomaTechnology in Cancer Research & Treatment 2016; 15(6): 780 doi: 10.1177/1533034615605248
50
Shanshan Wang, Ning Chen, Yuhan Chen, Lin Sun, Li Li, Hui Liu. Elevated GPC3 level promotes cell proliferation in liver cancerOncology Letters 2018;  doi: 10.3892/ol.2018.8754
51
Jyoji YAMATE. Stem cell pathology: histogenesis of malignant fibrous histiocytoma and characterization of myofibroblasts appearing in fibrotic lesionsJournal of Veterinary Medical Science 2023; 85(9): 895 doi: 10.1292/jvms.23-0225
52
J.A. Wertheim, H. Petrowsky, S. Saab, J.W. Kupiec-Weglinski, R.W. Busuttil. Major Challenges Limiting Liver Transplantation in the United StatesAmerican Journal of Transplantation 2011; 11(9): 1773 doi: 10.1111/j.1600-6143.2011.03587.x
53
Gregor Krings, Rageshree Ramachandran, Dhanpat Jain, Tsung-Teh Wu, Matthew M Yeh, Michael Torbenson, Sanjay Kakar. Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinomaModern Pathology 2013; 26(6): 782 doi: 10.1038/modpathol.2012.243
54
Zhen Wang, Yan-Jiang Han, Shun Huang, Meng Wang, Wen-Lan Zhou, Hong-Sheng Li, Quan-Shi Wang, Hu-Bing Wu. Imaging the expression of glypican-3 in hepatocellular carcinoma by PETAmino Acids 2018; 50(2): 309 doi: 10.1007/s00726-017-2517-z
55
Laetitia Fartoux, Thomas Decaens. Contribution of biomarkers and imaging in the management of hepatocellular carcinomaClinics and Research in Hepatology and Gastroenterology 2011; 35: S21 doi: 10.1016/S2210-7401(11)70004-3
56
Jian Li, Tiezheng Wang, Boxun Jin, Wenlei Li, Zhenshun Wang, Haitao Zhang, Yunjun Song, Ning Li. Diagnosis accuracy of serum glypican-3 level in patients with hepatocellular carcinoma: a systematic review with meta-analysisThe International Journal of Biological Markers 2018; 33(4): 353 doi: 10.1177/1724600818784409
57
Neven A. Hagag, Yasser B. M. Ali, Ahmed A. Elsharawy, Roba M. Talaat. Clinical Impact of Circulated miR-1291 in Plasma of Patients with Liver Cirrhosis (LC) and Hepatocellular Carcinoma (HCC): Implication on Glypican-3 ExpressionJournal of Gastrointestinal Cancer 2020; 51(1): 234 doi: 10.1007/s12029-019-00234-9
58
Eman A.E. Badr, Tarek E. Korah, Ashraf Abdel Ghani, Sawsan El-Sayed, Safaa Badr. Role of serum glypican-3 in the diagnosis and differentiation of small hepatocellular carcinoma from hepatitis-C virus cirrhosisAlexandria Journal of Medicine 2014; 50(3): 221 doi: 10.1016/j.ajme.2014.01.002
59
Regina Cheuk-Lam Lo, Irene Oi-Lin Ng. Hepatocellular tumors: Immunohistochemical analyses for classification and prognosticationChinese Journal of Cancer Research 2011; 23(4): 245 doi: 10.1007/s11670-011-0245-6
60
Iman Attia Abdelgawad, Ghada Ibrahim Mossallam, Noha Hassan Radwan, Heba Mohammed Elzawahry, Niveen Mostafa Elhifnawy. Can Glypican3 be Diagnostic for Early Hepatocellular Carcinoma among Egyptian Patients?Asian Pacific Journal of Cancer Prevention 2013; 14(12): 7345 doi: 10.7314/APJCP.2013.14.12.7345
61
Dongsheng Gu, Yongsheng Xie, Jingwei Wei, Wencui Li, Zhaoxiang Ye, Zhongyuan Zhu, Jie Tian, Xubin Li. MRI‐Based Radiomics Signature: A Potential Biomarker for Identifying Glypican 3‐Positive Hepatocellular CarcinomaJournal of Magnetic Resonance Imaging 2020; 52(6): 1679 doi: 10.1002/jmri.27199
62
Zhao-Shan Niu, Xiao-Jun Niu, Wen-Hong Wang, Jing Zhao. Latest developments in precancerous lesions of hepatocellular carcinomaWorld Journal of Gastroenterology 2016; 22(12): 3305-3314 doi: 10.3748/wjg.v22.i12.3305
63
Randa Mohamed MA Farag, Dujana AlAyobi, Khalid A Alsaleh, Hye-Joo Kwon, Afaf EL-Ansary, Emad Anwar Dawoud. Influence of Glypican-3 as Anewly Diagnostic Biomarker in Earlydetection of Hepatocellular Carcinoma among Saudi PatientsBiomedical and Pharmacology Journal 2018; 11(4): 1789 doi: 10.13005/bpj/1550
64
Tushar Patel, Denise Harnois. Assessment of response to therapy in hepatocellular carcinomaAnnals of Medicine 2014; 46(3): 130 doi: 10.3109/07853890.2014.891355
65
Ting-Shuo Huang, Yu-Chiau Shyu, Robin Turner, Huang-Yang Chen, Pei-Jer Chen. Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocolSystematic Reviews 2013; 2(1) doi: 10.1186/2046-4053-2-37
66
Vladimír Šámal, Tomáš Jirásek, Vít Paldus, Igor Richter, Ondřej Hes. Urachal yolk sac tumor penetrating the bladder as a diagnostic challenge: a case report and review of the literatureDiagnostic Pathology 2022; 17(1) doi: 10.1186/s13000-022-01190-y
67
Ravikiran Tekupalli, Santosh Anand, Sowbhagya Ramachandregowda, Anupama Sindhghatta Kariyappa. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 22022; : 195 doi: 10.1016/B978-0-323-98807-0.00019-3
68
Sarwat Fatima, John M Luk, Ronnie TP Poon, Nikki P Lee. Dysregulated expression of dickkopfs for potential detection of hepatocellular carcinomaExpert Review of Molecular Diagnostics 2014; 14(5): 535 doi: 10.1586/14737159.2014.915747
69
Jian Fan, Bin Lou, Wei Chen, Jie Zhang, Sha Lin, Fei-fei Lv, Yu Chen. Down-regulation of HDAC5 inhibits growth of human hepatocellular carcinoma by induction of apoptosis and cell cycle arrestTumor Biology 2014; 35(11): 11523 doi: 10.1007/s13277-014-2358-2
70
Tarek Mohamed Kamal Motawi, Nermin Abdel Hamid Sadik, Dina Sabry, Nancy Nabil Shahin, Sally Atef Fahim. rs2267531, a promoter SNP within glypican-3 gene in the X chromosome, is associated with hepatocellular carcinoma in EgyptiansScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-43376-3
71
Min Chen, Guohua Li, Jian Yan, Xiuzhi Lu, Jianwei Cui, Zhengxian Ni, Weizhong Cheng, Gengsun Qian, Jing Zhang, Hong Tu. Reevaluation of glypican-3 as a serological marker for hepatocellular carcinomaClinica Chimica Acta 2013; 423: 105 doi: 10.1016/j.cca.2013.04.026
72
Jia-Mei Dong, Rui-Qi Wang, Ning-Ning Yuan, Jia-Hao Guo, Xin-Yang Yu, Ang-Hui Peng, Jia-Yi Cai, Lei Xue, Zhi-Ling Zhou, Yi-Hao Sun, Ying-Yin Chen. Recent advances in optical aptasensors for biomarkers in early diagnosis and prognosis monitoring of hepatocellular carcinomaFrontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1160544
73
Yunsheng Zhao, Qin Gao, Liu Pei, Chunhua Wang, Liang Jin, Fei Liao. Current Status and Future Prospects of Biomarkers in the Diagnosis of Hepatocellular CarcinomaThe International Journal of Biological Markers 2017; 32(4): 361 doi: 10.5301/ijbm.5000299
74
Dahai Xu, Chang Su, Liang Sun, Yuanyuan Gao, Youjun Li. Performance of Serum Glypican 3 in Diagnosis of Hepatocellular Carcinoma: A meta-analysisAnnals of Hepatology 2019; 18(1): 58 doi: 10.5604/01.3001.0012.7863
75
Hyun Jung Lee, Jong Eun Yeon, Sang Jun Suh, Sun Jae Lee, Eileen L. Yoon, Keunhee Kang, Yang Jae Yoo, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Kwan Soo Byun. Clinical Utility of Plasma Glypican-3 and Osteopontin as Biomarkers of Hepatocellular CarcinomaGut and Liver 2014; 8(2): 177 doi: 10.5009/gnl.2014.8.2.177
76
Hui‐Lai Miao, Zhi‐Jian Pan, Chang‐Jiang Lei, Ji‐Yu Wen, Ming‐Yi Li, Zhong‐Kao Liu, Zhi‐Dong Qiu, Man‐Zhou Lin, Nian‐Ping Chen, Ming Chen. Knockdown of GPC3 inhibits the proliferation of Huh7 hepatocellular carcinoma cells through down‐regulation of YAPJournal of Cellular Biochemistry 2013; 114(3): 625 doi: 10.1002/jcb.24404
77
Tsung-Chieh Shih, Lijun Wang, Hsiao-Chi Wang, Yu-Jui Yvonne Wan. Glypican-3: A molecular marker for the detection and treatment of hepatocellular carcinomaLiver Research 2020; 4(4): 168 doi: 10.1016/j.livres.2020.11.003
78
Alessandra Tessitore, Germana Cicciarelli, Filippo Del Vecchio, Agata Gaggiano, Daniela Verzella, Mariafausta Fischietti, Valentina Mastroiaco, Antonella Vetuschi, Roberta Sferra, Remo Barnabei, Daria Capece, Francesca Zazzeroni, Edoardo Alesse. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J miceBMC Cancer 2016; 16(1) doi: 10.1186/s12885-015-2007-1
79
Agostino Colli, Tin Nadarevic, Damir Miletic, Vanja Giljaca, Mirella Fraquelli, Davor Štimac, Giovanni Casazza. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver diseaseCochrane Database of Systematic Reviews 2021; 2021(4) doi: 10.1002/14651858.CD013346.pub2
80
Zhejia Zhang, Linyong Xu, Zhiming Wang. Screening serum biomarkers for early primary hepatocellular carcinoma using a phage display techniqueJournal of Clinical Laboratory Analysis 2011; 25(6): 402 doi: 10.1002/jcla.20491
81
Ming-Chin Yu, Yun-Shien Lee, Sey-En Lin, Hsiang-Yao Wu, Tse-Ching Chen, Wei-Chen Lee, Miin-Fu Chen, Chi-Neu Tsai. Recurrence and Poor Prognosis Following Resection of Small Hepatitis B-Related Hepatocellular Carcinoma Lesions Are Associated with Aberrant Tumor Expression Profiles of Glypican 3 and OsteopontinAnnals of Surgical Oncology 2012; 19(S3): 455 doi: 10.1245/s10434-011-1946-2